Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-23

Clinical Trial Update: Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial is assessing prednisone in adults with an immune-mediated subtype of autism spectrum disorder; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)

Snippet

Sponsor: Christopher John McDougle, M.D. | Conditions: Autism Spectrum Disorder, Autism Spectrum Disorders | EARLY_Phase 1 | Status: NOT_YET_RECRUITING